Product image of Kipos (Colecalciferol) supplied by GNH India

Kipos

Active Ingredient:
Colecalciferol
Origin:
EU

Kipos (Colecalciferol)

Colecalciferol, the active ingredient in Kipos, is a Vitamin D presented as an oral dosage form for oral use. It treats vitamin D deficiency and supports bone health in adults and children.

GNH India supplies Kipos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Substipharm

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kipos is a vitamin D supplement that addresses disorders of calcium and phosphate metabolism.

  • Vitamin D deficiency: restores normal serum 25‑hydroxyvitamin D levels and improves bone mineralization.
  • Osteomalacia: alleviates bone softening, reducing bone pain and muscle weakness.
  • Rickets: prevents abnormal bone growth in children, supporting normal skeletal development.

How It Works

  • Colecalciferol (vitamin D3) is converted in the liver to 25‑hydroxyvitamin D and subsequently in the kidney to the active hormone 1,25‑dihydroxyvitamin D. This active form binds to the vitamin D receptor in intestinal cells, enhancing transcription of calcium‑binding proteins, which increases intestinal absorption of calcium and phosphate and promotes bone mineralization.

Side Effects

Adverse reactions may occur with excessive intake or individual sensitivity.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Constipation: reduced bowel movements.
  • Dry mouth: sensation of oral dryness.
  • Headache: transient cranial discomfort.
  • Fatigue: feeling of tiredness.
  • Hypercalciuria: elevated urinary calcium excretion.

Serious or Rare Side Effects

  • Hypercalcemia: excessive serum calcium causing weakness, arrhythmia, or renal stones.
  • Renal impairment: reduced kidney function due to calcium deposition.
  • Allergic reaction: rash, itching, or swelling.
  • Severe hypercalciuria: may lead to nephrolithiasis.
  • Hypersensitivity anaphylaxis: rare but potentially life‑threatening.
  • Persistent vomiting: may indicate severe toxicity.

Precautions & Warnings

Before using Kipos, consider the following safety measures.

  • Assess baseline calcium: ensure serum calcium is within normal range to avoid hypercalcemia.
  • Monitor renal function: patients with kidney disease should be observed for calcium accumulation.
  • Review concomitant vitamin D intake: avoid excessive total vitamin D from multiple sources.
  • Caution in elderly: higher risk of hypercalcemia and falls.
  • Pregnancy and lactation: use only if prescribed after risk‑benefit evaluation.
  • Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Kipos may interact with other medicines that affect calcium balance.

Major Interactions (Avoid)

  • Thiazide diuretics: increase risk of hypercalcemia.
  • Calcium supplements: additive effect on serum calcium levels.
  • Vitamin A excess: potentiates hypercalcemia.
  • Digitalis glycosides: heightened toxicity with elevated calcium.
  • High‑dose vitamin D analogues: may cause severe hypercalcemia.

Moderate Interactions (Monitor Closely)

  • Anticonvulsants (e.g., phenobarbital, phenytoin): may accelerate vitamin D metabolism, reducing efficacy.
  • Corticosteroids: can impair vitamin D activation, requiring dose adjustment.
  • Orlistat: may decrease absorption of fat‑soluble vitamins, including vitamin D.
  • Cholestyramine: can bind vitamin D, lowering its bioavailability.
  • Bisphosphonates: concurrent use may affect calcium homeostasis.

Frequently Asked Questions

Kipos contains colecalciferol, a form of vitamin D3, and is used to correct vitamin D deficiency, prevent osteomalacia in adults and rickets in children, and support overall bone health by enhancing calcium and phosphate absorption.

Colecalciferol is converted first in the liver to 25‑hydroxyvitamin D and then in the kidney to the active hormone 1,25‑dihydroxyvitamin D. This active form binds to vitamin D receptors in the intestine, stimulating the production of calcium‑binding proteins that increase calcium and phosphate uptake, which are essential for bone mineralization.

The appropriate dose of Kipos is determined by a prescriber based on the individual’s serum vitamin D level, age, weight, and clinical condition. Patients should follow the healthcare professional’s instructions and not self‑adjust the dosage.

Safety of colecalciferol during pregnancy or lactation should be evaluated by a healthcare professional. If the potential benefit justifies the possible risk, a prescriber may recommend Kipos, but it should only be used under medical supervision.

To order Kipos, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kipos provides colecalciferol, the natural form of vitamin D3, which is generally considered more potent and longer‑acting than vitamin D2 (ergocalciferol). Compared with high‑dose prescription formulations, Kipos is an over‑the‑counter product intended for routine supplementation and mild to moderate deficiency.

Kipos should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain potency and stability.

Kipos is taken orally, usually with food or a glass of water, as directed by a healthcare professional. The tablet (or capsule) should be swallowed whole and not crushed or chewed unless specifically advised.

The most serious risks involve excessive calcium levels, such as hypercalcemia, which can cause kidney stones, renal impairment, cardiac arrhythmias, and severe gastrointestinal symptoms. Prompt medical attention is required if signs of high calcium appear.

Individuals with known hypersensitivity to colecalciferol or any excipients, patients with hypercalcemia, severe renal disease, or those taking medications that significantly raise calcium levels should avoid Kipos unless a prescriber determines it is safe.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Colecalciferol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT